Skip to main content
. 2025 Jul;227(1):473–480. doi: 10.1192/bjp.2025.84

Table 1.

Demographics and key baseline measures

All randomised subjects VQW-765 Placebo Total
(n = 116) (n = 114) (n = 230)
Sex, n (%)
 Female 82 (70.69) 77 (67.54) 159 (69.13)
 Male 34 (29.31) 37 (32.46) 71 (30.87)
Age (years)
 Mean (s.d.) 41.04 (15.23) 41.72 (15.20) 41.38 (15.19)
Race, n (%)
 White 66 (56.90) 59 (51.75) 125 (54.35)
 Black or African-American 30 (25.86) 31 (27.19) 61 (26.52)
 Asian 13 (11.21) 19 (16.67) 32 (13.91)
 American-Indian or Alaska Native 3 (2.59) 1 (0.88) 4 (1.74)
 Native Hawaiian or other Pacific Islander 1 (0.86) 1 (0.88) 2 (0.87)
 Others 3 (2.59) 3 (2.63) 6 (2.61)
Body mass index (kg/m2)
 Mean (s.d.) 28.10 (6.24) 29.10 (7.32) 28.60 (6.80)
17-item HAM-D
 Mean (s.d.) 4.18 (4.06) 4.32 (4.28) 4.25 (4.16)
PSAS
 Mean (s.d.) 69.99 (6.44) 70.39 (6.79) 70.19 (6.60)
LSAS
 Mean (s.d.) 83.14 (24.65) 83.50 (26.31) 83.32 (25.43)
 LSAS ≥60, n (%) 97 (83.62) 92 (80.70) 189 (82.17)

HAM-D, Hamilton Depression Rating Scale; PSAS, Public Speaking Anxiety Scale; LSAS, Liebowitz Social Anxiety Scale.